ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Broker Notes
Bell Potter names more of the best ASX 200 shares to buy
How to invest
5 ASX 200 shares for trying to build wealth after 50
How to invest
Got $5,000? 5 ASX shares to buy for lasting wealth
Share Fallers
Why Cettire, Harvey Norman, Orora, and ResMed shares are sinking today
Opinions
Here's why I think the Resmed share price should be 18% higher
How to invest
Where to invest $8,000 in April 2024
Defensive Shares
4 defensive ASX shares to own in a greedy market: Macquarie
Opinions
My top 3 ASX shares to consider buying before April
How to invest
2 ASX shares that could help set you up for life
Healthcare Shares
1 ASX stock to consider buying that could be the next ResMed
Healthcare Shares
GLP-1 obesity medicines do the opposite of what ResMed stock investors feared
Growth Shares
A once-in-a-decade chance to get rich buying ASX growth stocks?
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.